Author:
Rosyold Elizabeth,Schilder Russell,Walczak Judy,DiFino S. M.,Flynn P. J.,Banerjee T. K.,Heim W. J.,Engstrom Paul E.,Ozols Robert F.,O'Dwyer Peter J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference20 articles.
1. Ardalan B, Glazer RI, Kensler TW, Jayaram HN, Pham TV, Macdonald JS, Cooney DA (1981) Synergistic effect of 5-fluorouracil andN-(phosphonacetyl)-l-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma. Biochem Pharmacol 30:2045?2049
2. Ardalan B, Singh G, Silberman H (1988) A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or withoutN-(phosphonacetyl)-l-aspartic acid in patients with advanced pancreatic and colorectal cancers. J Clin Oncol 6: 1053?1058
3. Brennan MF, Kinsella T, Friedman M (1989) Cancer of the pancreas. In: DeVita, VT, Heller S, Rosenberg SA, (eds) Cancer principles and practice of oncology, 3rd edn. Lippincott, Philadelphia, pp 800?835
4. Caspar ES, Vale K, Williams LJ, Martin DS, Young CW (1983) Phase I and clinical pharacological evaluation of biochemical modulation with N-(phosphonacetyl)-L-aspartic acid. Cancer Research 43:2334?2339
5. DeCaprio JA, Arbuck SG, Mayer RJ (1989) Phase II study of weekly 5-fluoracil (5-FU) and folinic acid (FA) in previously untreated patients with unresectable measurable pancreatic adenocarcinoma. Proc Am Soc Clin Oncol 8:100
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献